Fact CheckerSign in

NCT05691452Completed

Technology Based Sedentary Reduction Intervention in Patients With Type 2 Diabetes

Technology-Based Sedentary Reduction Intervention in Patients With Type 2 Diabetes: A Pilot Study

Source: ClinicalTrials.gov · Last updated 19 Mar 2025

Brief summary (registry, in English)

The purpose of this study is to develop and test an 8-week sedentary behavior reduction intervention ("Sit Less" program) for patients with type 2 diabetes. The program aims to reduce and break sitting times among this population using an objective activity monitor and mHealth. The investigators will test the program to help diabetes patients break up sitting time, reduce daily sitting time, and move more. The investigators will also study preliminary effects of the SB reduction intervention on light physical activity, cardiometabolic markers and patient-centered outcomes, and whether diabetes patients like the program and can follow it.

Status (registry)
Completed
Study type
Interventional
Enrollment
31 (actual)
First submitted
5 Jan 2023
Start date
24 Jan 2023
Primary completion date
5 Jan 2024
Lead sponsor
Vanderbilt University
NCT number
NCT05691452

What you commit to

  • Study type: Interventional
  • Participants enrolled: 31
  • From 24 Jan 2023 to the primary completion date, 5 Jan 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • currently using an activity tracker

Other illness

  • patients who are classified as unstable (e.g. heart failure, uncontrolled arrhythmia) or have kidney disease that limits daily water intake, or any other conditions contradictory to standing or walking

Lab values

  • random blood glucose \>300

Other

  • use of insulin
  • currently participating in exercise or other research programs
  • non-English speaking
  • currently pregnant

Who the study is looking for

  • ages 18 and above
  • diagnosed with type 2 diabetes
  • self-reported HbA1C\<13
  • self-report of sitting ≥ 8hr/day
  • ability to stand and walk
  • ownership of a smartphone.

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Vanderbilt University
Coordinator of this site? Confirm its status
NashvilleUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.